DiagnaMed Launches Ontario Hydrogen Exploration Campaign in Conjunction with QIMC and INRS; Strengthens Board
DiagnaMed Holdings Corp. (CSE: DMED) has launched a major hydrogen exploration campaign in Ontario in partnership with INRS and Quebec Innovative Materials Corp. The initiative will implement over 2,000 soil gas samples to identify high-potential natural hydrogen zones, replicating INRS-QIMC's successful exploration model from Quebec.
The exploration will be led by Dr. Marc Richer-Laflèche in collaboration with Temiscamingue First Nations. The program aims to leverage the proven geological model that demonstrated high hydrogen measurements and fault-controlled advection in Quebec. Additionally, the company announced the appointment of André Turmel to its Board of Directors, while Carlo Sansalone has stepped down.
DiagnaMed Holdings Corp. (CSE: DMED) ha avviato una importante campagna di esplorazione dell'idrogeno in Ontario in collaborazione con INRS e Quebec Innovative Materials Corp. L'iniziativa prevede l'analisi di oltre 2.000 campioni di gas del suolo per individuare zone ad alto potenziale di idrogeno naturale, replicando il modello di esplorazione di successo di INRS-QIMC in Quebec.
L'esplorazione sarà guidata dal Dott. Marc Richer-Laflèche in collaborazione con le Prime Nazioni di Temiscamingue. Il programma mira a sfruttare il modello geologico comprovato che ha evidenziato elevate concentrazioni di idrogeno e un trasporto controllato da faglie in Quebec. Inoltre, la società ha annunciato la nomina di André Turmel nel suo Consiglio di Amministrazione, mentre Carlo Sansalone si è dimesso.
DiagnaMed Holdings Corp. (CSE: DMED) ha iniciado una importante campaña de exploración de hidrógeno en Ontario en asociación con INRS y Quebec Innovative Materials Corp. La iniciativa implementará más de 2,000 muestras de gas del suelo para identificar zonas con alto potencial de hidrógeno natural, replicando el exitoso modelo de exploración de INRS-QIMC en Quebec.
La exploración estará liderada por el Dr. Marc Richer-Laflèche en colaboración con las Primeras Naciones de Temiscamingue. El programa busca aprovechar el modelo geológico probado que demostró altas mediciones de hidrógeno y una advección controlada por fallas en Quebec. Además, la empresa anunció el nombramiento de André Turmel en su Junta Directiva, mientras que Carlo Sansalone ha renunciado.
DiagnaMed Holdings Corp. (CSE: DMED)는 INRS 및 Quebec Innovative Materials Corp와 협력하여 온타리오에서 대규모 수소 탐사 캠페인을 시작했습니다. 이 프로젝트는 2,000개 이상의 토양 가스 샘플을 채취하여 고잠재력 천연 수소 지역을 식별하며, INRS-QIMC의 퀘벡 성공 탐사 모델을 재현합니다.
탐사는 Dr. Marc Richer-Laflèche가 Temiscamingue 퍼스트 네이션과 협력하여 주도할 예정입니다. 이 프로그램은 퀘벡에서 높은 수소 농도와 단층에 의해 제어되는 대류를 입증한 검증된 지질 모델을 활용하는 것을 목표로 합니다. 또한, 회사는 André Turmel을 이사회에 임명했으며, Carlo Sansalone는 사임했습니다.
DiagnaMed Holdings Corp. (CSE : DMED) a lancé une importante campagne d'exploration de l'hydrogène en Ontario en partenariat avec INRS et Quebec Innovative Materials Corp. L'initiative prévoit la collecte de plus de 2 000 échantillons de gaz du sol afin d'identifier des zones à fort potentiel d'hydrogène naturel, en reproduisant le modèle d'exploration réussi d'INRS-QIMC au Québec.
L'exploration sera dirigée par le Dr Marc Richer-Laflèche en collaboration avec les Premières Nations de Temiscamingue. Le programme vise à tirer parti du modèle géologique éprouvé qui a démontré des mesures élevées d'hydrogène et une advection contrôlée par des failles au Québec. Par ailleurs, la société a annoncé la nomination de André Turmel à son conseil d'administration, tandis que Carlo Sansalone a démissionné.
DiagnaMed Holdings Corp. (CSE: DMED) hat in Zusammenarbeit mit INRS und Quebec Innovative Materials Corp eine umfangreiche Wasserstoff-Erkundungskampagne in Ontario gestartet. Die Initiative umfasst die Entnahme von über 2.000 Boden-Gasproben, um Gebiete mit hohem Potenzial für natürlichen Wasserstoff zu identifizieren und das erfolgreiche Erkundungsmodell von INRS-QIMC aus Quebec zu replizieren.
Die Erkundung wird von Dr. Marc Richer-Laflèche in Zusammenarbeit mit den Temiscamingue First Nations geleitet. Das Programm zielt darauf ab, das bewährte geologische Modell zu nutzen, das in Quebec hohe Wasserstoffwerte und durch Störungen gesteuerte Advektion nachgewiesen hat. Zudem wurde die Ernennung von André Turmel in den Vorstand bekannt gegeben, während Carlo Sansalone zurückgetreten ist.
- None.
- Board restructuring with departure of Carlo Sansalone
- Early-stage exploration with no guaranteed results
Toronto, Ontario--(Newsfile Corp. - July 3, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) ("DiagnaMed" or the "Company"), is pleased to announce it has signed an agreement with the Institut national de la recherche scientifique (INRS) to initiate a comprehensive hydrogen exploration campaign on its Ontario properties, in conjunction with Quebec Innovative Materials Corp. (CSE: QIMC) ("QIMC"). The exploration will be led by Dr. Marc Richer-Laflèche and will include collaboration with members of the Temiscamingue First Nations. Leveraging the innovative geological exploration model successfully developed and deployed by INRS and QIMC at St-Bruno-de-Guigues, Quebec, the Ontario program will include an extensive campaign of over 2,000 soil gas samples aimed at identifying high-potential natural hydrogen zones.
The INRS-QIMC exploration model has yielded exceptional results in Quebec, characterized by notably high hydrogen (H₂) measurements indicative of significant geological processes:
Rapid, fault-controlled advection demonstrated by sustained high hydrogen (H2) levels.
Elevated hydrogen concentrations, suggesting an actively supplied deep source, potentially from radiolysis or iron oxidation processes migrating along fault lines.
The model confirms a classic "advective fault" degassing system, ranking among the most compelling documented examples globally for natural hydrogen production
DiagnaMed anticipates replicating this success in Ontario, significantly enhancing the understanding and valuation of its exploration assets.
John Karagiannidis, President of DiagnaMed, stated, "We are excited to launch this exploration initiative alongside QIMC and INRS. The expertise of Dr. Richer-Laflèche and our collaboration with the Temiscamingue First Nations underscore our commitment to responsible, community-engaged exploration. This campaign represents a major step forward in unlocking Ontario's natural hydrogen potential and creating sustainable value for our shareholders."
DiagnaMed is also pleased to announce important governance enhancements. The Company warmly welcomes Mr. André Turmel to its Board of Directors. Mr. Turmel brings extensive expertise in corporate governance, legal frameworks, and resource development, providing valuable strategic guidance as DiagnaMed expands its exploration initiatives. Concurrently, Mr. Carlo Sansalone has resigned from the Board. DiagnaMed expresses its sincere gratitude to Mr. Sansalone for his dedicated service and meaningful contributions to the Company's growth.
About DiagnaMed Holdings Corp.
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a Canadian technology innovator specializing in advanced hydrogen extraction technologies designed to support the rapidly growing natural hydrogen industry. Focused on commercial scalability, DiagnaMed aims to deliver cost-effective, sustainable, and efficient hydrogen solutions critical for global energy security and decarbonization. Visit DiagnaMed.com.
For more information, please contact:
John Karagiannidis, President and CEO
DiagnaMed Holdings Corp.
Tel: 514-726-7058
Email: info@diagnamed.com
Website: www.diagnamed.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
Cautionary Statement
Certain statements in this news release are forward-looking statements, including with respect to future plans, and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding-looking wording such as "will", "may", "expect", "could", "can", "estimate", "anticipate", "intend", "believe", "projected", "aims", and "continue" or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to, business, economic and capital market conditions, the ability to manage operating expenses, and dependence on key personnel. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, anticipated costs, and the ability to achieve goals. Factors that could cause the actual results to differ materially from those in forward-looking statements include, the continued availability of capital and financing, litigation, failure of counterparties to perform their contractual obligations, loss of key employees and consultants, and general economic, market or business conditions. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption "Risk Factors" in Company's management's discussion and analysis for the Three and Six Months Ended March 31, 2025 ("MD&A"), dated May 28, 2025, which is available on the Company's profile at www.sedarplus.ca. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/257642
FAQ
What is DiagnaMed's new hydrogen exploration initiative in Ontario?
Who will lead DiagnaMed's Ontario hydrogen exploration program?
What exploration model will DGNMF use in Ontario?
Who is joining DiagnaMed's Board of Directors?
What are the key features of the INRS-QIMC exploration model?
